Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
作者： Bernard Bourrie , Samir Jegham , Pierre Casellas , Pierre Perreaut , Sylvie Cosnier-Pucheu
DOI:
关键词:
摘要: The present invention relates to combinations of N-[2-(2,1,3-benzothiadiazol-5- ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea and cytarabine their use for treating AML or CML.
lens.org 参考文章(5)
Claude Muneaux, Bernard Bourrie, Samir Jegham, Pierre Casellas, Pierre Perreaut, Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same ,(2006)
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Martin S. Tallman, D. Gary Gilliland, Jacob M. Rowe, Drug therapy for acute myeloid leukemia. Blood. ,vol. 106, pp. 1154- 1163 ,(2005) , 10.1182/BLOOD-2005-01-0178
J. M. Bennett, D. Catovsky, Marie-Theregse Daniel, G. Flandrin, D. A. G. Galton, H. R. Gralnick, C. Sultan, Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. British Journal of Haematology. ,vol. 33, pp. 451- 458 ,(1976) , 10.1111/J.1365-2141.1976.TB03563.X
Bernard Bourrie, Pierre Casellas, Novel therapeutic use for treating leukaemia ,(2007)